(USD) | Nov 2023 | Q/Q |
---|---|---|
Revenue | 99.4MM | +3% |
Gross Profit | 44.9MM | - |
Cost Of Revenue | 54.5MM | -1% |
Operating Income | -31.7MM | -10% |
Operating Expenses | 76.6MM | -0% |
Net Income | -21.1MM | -36% |
G&A | 15.5MM | -5% |
Marketing | 26.2MM | +9% |
Amortization | 9.1MM | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Paymentus (PAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Accolade, Inc. (Nasdaq: ACCD) today announced it has been named a winner of the Business Intelligence Group's Artificial Intelligence Excellence Awards program for its application of Natural Language Processing. This award recognizes companies leveraging AI technology to solve real-world problems. Accolade is one of the only healthcare organizations recognized this year for excellence in AI.
Accolade, Inc. (Nasdaq: ACCD) announced today the promotion of Kelsi McDonald Harris as Chief People Officer and Senior Vice President.
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: Raymond James 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5 at 8:05 am ETBarclays 26th Annual Global Healthcare Conference in Miami Beach on Wednesday, March 13 at 1:35 pm ET A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. A
Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem. The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.
In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]
Here is how Accolade (ACCD) and Palantir Technologies Inc. (PLTR) have performed compared to their sector so far this year.
The consensus price target hints at a 25.6% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AxoGen, Western Digital, Accolade and Credo Technology Group are part of the Screen of the Week article.
Accolade, Inc. (Nasdaq: ACCD) today announced that Kindbody, a technology-driven fertility clinic network and family-building benefits provider for employers, will join the company's Trusted Partner Ecosystem to offer Accolade customers comprehensive, clinically guided support and care throughout a member's fertility and family-building journey, all backed by a new cost savings performance guarantee.